Related Experiment Video
Updated: Mar 14, 2026
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.1K
[Overview of the Ebola vaccines in pre-clinical and clinical development]
1GSK Vaccines R&D, 150 Beach Road, unit 22-00, 189720, Singapore, Singapore. philippe.x.buchy@gsk.com.
Bulletin De La Societe De Pathologie Exotique (1990)
|September 21, 2016
Abstract:
The Ebola epidemic that occurred in West Africa between 2013-2016 significantly accelerated the research and development of Ebola vaccines. Few dozens of clinical trials have been recently conducted leading to opportunities to test several new vaccine candidates. Other vaccines are still in early development phases (table 1). This paper provides an overview of the new developments in that area.
Related Concept Videos
01:28Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
00:42Cross-reactivity
33.7K
Overview
33.7K